相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Angiotensin II type I receptor agonistic autoantibodies are associated with poor allograft survival in liver retransplantation
Qingyong Xu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
IgG4 donor-specific HLA antibody profile is associated with subclinical rejection in stable pediatric liver recipients
Annette M. Jackson et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Outcome of Liver Transplant Patients With Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibodies
Arnaud Del Bello et al.
LIVER TRANSPLANTATION (2020)
Extracellular vesicles derived from injured vascular tissue promote the formation of tertiary lymphoid structures in vascular allografts
Melanie Dieude et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
B cell clonal expansion within immune infiltrates in human cardiac allograft vasculopathy
Carolina Moore et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group
Carrie A. Schinstock et al.
TRANSPLANTATION (2020)
Discovery of non-HLA antibodies associated with cardiac allograft rejection and development and validation of a non-HLA antigen multiplex panel: From bench to bedside
Carrie L. Butler et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Rejection in the setting of non-HLA antibody: New tools for navigating bench to bedside
Annette M. Jackson et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report
Anat R. Tambur et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Precision transplant pathology
Michelle A. Wood-Trageser et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2020)
New insights into immune mechanisms of antiperlecan/LG3 antibody production: Importance of T cells and innate B1 cells
Lauriane Padet et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens
Marianne Delville et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients
Carmen Lefaucheur et al.
KIDNEY INTERNATIONAL (2019)
Injury derived autoimmunity: Anti-perlecan/LG3 antibodies in transplantation
Melanie Dieude et al.
HUMAN IMMUNOLOGY (2019)
Is There a Role for Natural Antibodies in Rejection Following Transplantation?
Emmanuel Zorn et al.
TRANSPLANTATION (2019)
Compelling scientific and clinical evidence that non-HLA specific antibodies impact graft outcome independently and in concert with donor HLA specific antibodies
Nancy L. Reinsmoen
HUMAN IMMUNOLOGY (2019)
Editorial: Autoantibodies
Rikard Holmdahl et al.
FRONTIERS IN IMMUNOLOGY (2019)
The impact of alloantibodies directed against the second donor on long-term outcomes of repeat liver transplantation
Qingyong Xu et al.
HEPATOBILIARY SURGERY AND NUTRITION (2019)
Preformed donor-specific antibodies do not affect the 1-year allograft survival in living donor liver transplantation
Hyeyoung Kim et al.
CLINICAL TRANSPLANTATION (2018)
Human leukocyte antigen compatibility and lymphocyte cross-matching play no significant role in the current adult-to-adult living donor liver transplantation
Amr Badawy et al.
CLINICAL TRANSPLANTATION (2018)
Pre-transplant Screening for Non-HLA Antibodies: Who should be Tested?
Mary Carmelle Philogene et al.
HUMAN IMMUNOLOGY (2018)
Donor-specific anti-HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation
Anne Claire den Dulk et al.
CLINICAL TRANSPLANTATION (2018)
The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications
Heloise Cardinal et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development
Chris Wiebe et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts
Jacqueline G. O'Leary et al.
TRANSPLANTATION (2017)
Non-HLA Antibodies May Accelerate Immune Responses After Intestinal and Multivisceral Transplantation
Undine Ariane Gerlach et al.
TRANSPLANTATION (2017)
The Presence of Pretransplant Antiphospholipid Antibodies IgA Anti-β-2-Glycoprotein I as a Predictor of Graft Thrombosis After Renal Transplantation
Jose Maria Morales et al.
TRANSPLANTATION (2017)
A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome
Nancy L. Reinsmoen et al.
TRANSPLANTATION (2017)
Anti-LG3 Antibodies Aggravate Renal Ischemia-Reperfusion Injury and Long-Term Renal Allograft Dysfunction
B. Yang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Donor-Specific HLA Antibodies in Living Versus Deceased Donor Liver Transplant Recipients
J. Levitsky et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Antibodies against angiotensin II type 1 receptor (AT1R) and endothelin receptor type A (ETAR) in systemic sclerosis (SSc)-response
Gabriela Riemekasten et al.
AUTOIMMUNITY REVIEWS (2016)
Preformed donor-specific HLA antibodies are associated with increased risk of early mortality after liver transplantation
Jennifer A. McCaughan et al.
CLINICAL TRANSPLANTATION (2016)
The importance of non-HLA antibodies in transplantation
Qiuheng Zhang et al.
NATURE REVIEWS NEPHROLOGY (2016)
Autoimmunity after liver transplantation: a frequent event but a rare clinical problem
Antonella Foschi et al.
CLINICAL TRANSPLANTATION (2015)
The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection
Melanie Dieude et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Prospective Monitoring of Donor-specific Anti-HLA Antibodies After Intestine/Multivisceral Transplantation: Significance of De Novo Antibodies
Chandrashekhar Kubal et al.
TRANSPLANTATION (2015)
Antibody-mediated rejection in liver transplantation: Current controversies and future directions
Timucin Taner et al.
LIVER TRANSPLANTATION (2014)
Anti-Angiotensin Type 1 Receptor Antibodies in Chronic Graft-Versus-Host Disease
Andrada Chiron et al.
TRANSPLANTATION (2014)
Association of Anti-Human Leukocyte Antigen and Anti-Angiotensin II Type 1 Receptor Antibodies With Liver Allograft Fibrosis After Immunosuppression Withdrawal
Hidenori Ohe et al.
TRANSPLANTATION (2014)
Antiperlecan Antibodies Are Novel Accelerators of Immune-Mediated Vascular Injury
H. Cardinal et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation
Jacqueline G. O'Leary et al.
LIVER TRANSPLANTATION (2013)
Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation
Brian D. Tait et al.
TRANSPLANTATION (2013)
The Perlecan Fragment LG3 Is a Novel Regulator of Obliterative Remodeling Associated With Allograft Vascular Rejection
Mathilde Soulez et al.
CIRCULATION RESEARCH (2012)
Desensitization in HLA-Incompatible Kidney Recipients and Survival
Robert A. Montgomery et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection
D Dragun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)